Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy. [electronic resource]
Producer: 20130412Description: 321-35 p. digitalISSN:- 1432-0851
- Antigens, Neoplasm -- immunology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cancer Vaccines -- pharmacology
- Cells, Cultured
- Combined Modality Therapy
- Cytokines -- metabolism
- Dendritic Cells -- drug effects
- Humans
- Immunotherapy
- Inhibitor of Apoptosis Proteins -- antagonists & inhibitors
- Leukocytes, Mononuclear -- drug effects
- NF-kappa B -- metabolism
- Peptides -- pharmacology
- T-Lymphocytes -- drug effects
- Thiazoles -- pharmacology
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.